First, cell cycle analysis and apoptosis assay were performed on both A2780 (human ovarian carcinoma-sensitive to cisplatin) and A2780-CP (human ovarian carcinoma-resistant to cisplatin) cell lines after being treated with the combination. This evidence concerns the gene CP and ovarian carcinoma.